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Regulatory T cells (Tregs) are CD4+Foxp3+ cells that modulate autoimmune responses. Tregs have been shown to be also involved
during the immune response against infectious agents. The aim of this work is to study the role of Tregs during the infection with
the intracellular protozoan Toxoplasma gondii. Resistant BALB/c mice were injected with 200μg of anti-CD25mAb (clone PC61)
and 2 days later they were infected with 20 cysts of the ME49 strain of T. gondii. We observed that depleted mice showed 50–60%
mortality during the acute infection. When FACS analysis was carried out, we observed that although injection of PC61mAb
eliminated 50% of Tregs, infected-depleted mice showed a similar percentage of CD25+Foxp3− (activated T cells, Tact) to those
observed in infected nondepleted animals, demonstrating that in our depletion/infection system, injection of PC61mAb did not
hamperTcellactivationwhilepercentageofTregswasreducedby75%10dayspostinfection.WeconcludedthatTregsareessential
during protection in the acute phase of T. gondii infection.
1.Introduction
Toxoplasma gondii (T. gondii) is an intracellular parasite
and the etiological agent of toxoplasmosis. Although the
infection is asymptomatic in most immunocompetent indi-
viduals, toxoplasmosis may cause severe complications in
immunocompromised individuals [1, 2]. If T. gondii infec-
tion occurs during pregnancy, transplacental transmission
can occur, leading to abortion or congenital malformations
[2–5].
The immune response against T. gondii has been largely
characterized and it has been demonstrated that cell medi-
ated immunity is essential to control infection [2, 6, 7],
involving synergy between CD4+ and CD8+ T cells [8, 9]. T.
gondii triggers the production of IL-12, mainly by dendritic
cells [10–12],whichstimulate NK cellsand Tlymphocytes to
secrete large amounts of IFN-γ, a key cytokine for protection
against this parasite [10, 13, 14]. Thus, protection against T.
gondii is dependent on a TH1 response [15]. However IL-
10 is also required for prevention of development of IFN-γ
mediated pathology [16].
Regulatory T cells (Tregs) are a subset of CD4+ Tc e l l s
that control the immune response by suppressing many
lymphocyte eﬀector functions [17–19]. Natural Tregs consti-
tutively express CD25 (the α chain of the IL-2 receptor) [20],
CTLA-4 [21], and the forkhead family transcription factor
Foxp3 [22, 23], which is required for their development and
function [22]. Although initially described for preventing
autoimmune responses [20, 24, 25], it has also been demon-
strated that they can regulate the immune response against
infectious agents [26–29]. For example, in vivo depletion
of CD25+ cells leads to an increase in the production of
IFN-γ in animals infected with Plasmodium chabaudi adami
[30]andTrypanosomacongolense [31],orinanimalsinfected
with Schistosoma mansoni to an increased production of
IFN-γ, IL-4, IL-5, and IL-13 [32], indicating that Tregs can2 Journal of Biomedicine and Biotechnology
control both TH1 and TH2 responses. During infection with
Plasmodium berghei [33]o rLitomosoides sigmodontis [34],
depletion of Tregs leads to control or elimination of the
parasites, respectively.
The aim of this paper is to study the role of Tregs during
the acute infection of T. gondii in the resistant BALB/c strain
of mice. We carried out depletion experiments by injection
of the PC61 mAb in mice followed by infection with the
typeIIstrainME49,andanalyzedmortality.SincePC61mAb
injection could also eliminate other cell subtypes expressing
CD25, mainly activated T cells (Tact), we also studied the
CD4+ T cell subsets aﬀected by injection of the PC61 mAb.
2.MaterialsandMethods
2.1. Mice. Six—eight-week-old female BALB/cAnN mice,
weighing 18–20g, and Swiss mice, were bred in our animal
house and maintained in pathogen-free conditions. All
protocols depicted in this paper were approved by the local
Bioethics Committee for Animal Research.
2.2. Parasites. The ME49 strain of T. gondii was maintained
in Swiss mice as previously described [35]. Brieﬂy, brains
from infected mice were removed and homogenized in
Dulbecco’s Phosphate Buﬀered Saline (DPBS); the number
of cysts was enumerated and mice were infected intraperi-
toneally with 10 cysts; this procedure was carried out every
2–4 months. For peroral infection, mice anesthetized with
Sevorane (ABBOTT, Mexico City, Mexico) were infected
with 20 cysts by gavage in 0.1mL DPBS.
2.3. Hybridomas and mAbs. The PC61 hybridoma secreting
rat IgG1 against murine CD25 was obtained from the
American Type Culture Collection (ATCC, Manassas, VA).
The F41D1 hybridoma, secreting an unrelated rat IgG1
mAb (isotype control), was a kind gift of Dr. Olivier
Denis (Institut Scientiﬁque de Sant´ e Publique, Brussels,
Belgium). Hybridomas were grown on CD Hybridoma
Medium (GIBCO, Grand Island, NY, USA) and mAbs were
obtained after ammonium sulfate (45%w/v) precipitation.
After extensive dialysis against PBS, antibody concentration
was determined by spectrophotometry at 280nm. Antibod-
ies were resuspended in PBS at 1-2mg/mL and stored at
−20◦C until used.
2.4. CD25+ TC e l l sD e p l e t i o nI nV i v oa n dI n f e c t i o n .Unless
otherwise stated, mice were injected intraperitoneally (ip)
with 200μg of puriﬁed PC61 mAb or control isotype at day
−2. Two days later (day 0), mice were infected perorally
as described above. Depletion was conﬁrmed by analyzing
CD4+CD25+ or CD4+CD25+Foxp3+ cells, in peripheral
blood samples when mice were infected. Weight and cumu-
l a t i v em o r t a l i t yw e r er e c o r d e dd a i l y ;s u r v i v a lc u r v e sw e r e
compared by the logrank test using the Prism software
(GraphPad, San Diego, CA).
2.5. Immunoﬂuorescence. Spleen cells (1 × 106) were incu-
bated (30 minutes, 4◦C) with anti-CD4-FITC or -TC (clone
RM4-5, Caltag, Burlingame, CA), anti-CD4-PerCP (Biole-
gend, San Diego CA), anti-CD25-PE or –APC (clone PC61
5.3, Caltag), or anti-CD25-PE (Clone 7D4, Miltenyi Biotec,
Auburn, CA) in 100μL of washing buﬀer (DPBS + 1% FCS
+ 0.1% NaN3). After washing 3 times, cells were suspended
in DPBS and analyzed immediately. For Foxp3 detection,
we used the Foxp3 Staining Buﬀer Set (eBioscience, San
Diego, CA) with anti-Foxp3-Alexa Fluor 488 (clone FJK-
16s, eBioscience) following the indications provided by the
manufacturer.
2.6.FlowCytometry. Flowcytometryanalysiswasperformed
on a FACScalibur or a FACScan cytometer (Becton Dick-
inson, San Jose, CA), running the Cell Quest program
(BectonDickinson).Lymphocyteswereidentiﬁedbyforward
scatter (FSC) and side scatter (SSC) characteristics, gated
and further analyzed. Detailed analysis of each experiment is
indicated in each ﬁgure legend. Samples were analyzed using
the FlowJo software V. 5.7.2 (Tree Star, Ashland OR).
3. Results and Discussion
We carried out depletion studies by injection of the PC61
mAb to analyze the role of Tregs in the resistant BALB/c
strain of mice during the infection with the type II strain
ME49 of T. gondii. In the literature we found many protocols
for Tregs depletion using the PC61 mAb in diﬀerent models,
using a wide range of mAb concentrations, from 100μg
to 1mg [32, 33, 36–41], or even several injections of the
PC61 mAb before and during infection [30, 42]. To reduce
the possibility of Tact elimination due to high antibody
concentrations, we tested the lowest doses reported of PC61
mAb (100μg and 200μg) by ip injection. Two days later we
analyzed CD4+CD25+ cells to determine if depletion was
achieved, since mice would be infected at this time point. We
used the PC61 mAb in the FACS analysis because McNeill
et al. [37], using Foxp3-GFP transgenic mice, demonstrated
that detection of CD25+ cells in PC61-depleted mice using
either the 7D4 or the PC61 mAbs showed similar results
[37]. As can be seen in Figure 1, injection of either 100
(Figure 1(b)) or 200μg( Figure 1(c)) of the PC61 mAb leads
to similar levels of depletion of CD4+CD25+ cells in the
spleen. Even though depletion eﬃciency was the same by the
day we intended to infect the animals, we were concerned
about how long would the depletion lasted. During the ﬁrst
week after injection of the PC61 mAb (Figure 2), depletion
eﬃciency was very similar using both doses, but at 10 days
post-depletion, a higher number of CD4+CD25+ cells were
observed in animals treated with 100μg when compared
to cells from animals treated with 200μg. At 14 days post
depletion, about 83% of cells were already detected in both
groups of animals. These results show that injection with
200μg leads to a depletion of CD25+ cells for at least 10 days.
Recovery of CD4+CD25+ is slightly faster in animals treated
with 100μg mAb; at 14 days, CD4+CD25+ cells from both
groups reached almost normal levels. We thus chose 200μg
of PC61 mAb for the subsequent experiments.
In order to study the role of Tregs during infection with
T. gondii, resistant BALB/c mice were depleted of CD25+
cells, and 2 days later they were perorally infected with 20
cysts of the ME49 strain. Since CD25 is a molecule expressedJournal of Biomedicine and Biotechnology 3
100 101 102 103
CD4-FITC
100
101
102
103
9.9
C
D
2
5
-
P
E
(a)
100 101 102 103
CD4-FITC
100
101
102
103
0.49
(b)
100 101 102 103
CD4-FITC
100
101
102
103
1.03
(c)
Figure 1: Injection of PC61 mAb depletes CD4+CD25+ cells. BALB/c mice (2 animals per group) were injected ip with DPBS (a), 100μg
(b), or 200μg (c) of puriﬁed anti-CD25 mAb (PC61). Two days later, spleen cells were obtained; immunoﬂuorescence was carried out using
anti-CD4-FITC and anti-CD25-PE mAbs, and cells were analyzed by FACS. The lymphocyte region was ﬁrst identiﬁed by FSC and SSC
characteristics, gated, and 10,000 gated events were captured. Numbers indicate % of CD4+CD25+ cells within the CD4+ population.
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Figure 2: Kinetics analysis of the depletion of CD4+CD25+ cells. BALB/c mice were injected ip with 100μg ((a)–(e)) or 200μg ((f)–(j))
of PC61 mAb. Spleen cells were obtained at diﬀerent time points and immunoﬂuorescence was carried out as described in Figure 1 using
anti-CD4-FITC and anti-CD25-APC mAbs. The lymphocyte region was ﬁrst identiﬁed and gated by FSC and SSC characteristics, the CD4+
region was subgated and 10,000 CD4+ events were captured. Numbers indicate % of CD4+CD25+ cells within the CD4+ population.
by other cell types, including activated CD4+ T cells, and
Foxp3 is exclusively expressed by Tregs and is required for
their development and function [22], we thus analyzed the
depletion of Foxp3+ cells (Tregs) the day of infection (2 days
after depletion). We found that only 53% of Foxp3+ cells
were eliminated by injection of the PC61 mAb (Figure 3),
conﬁrming results previously reported [37].
Weight changes and mortality were analyzed for 25 days
after depletion and infection (Figure 4). All mice lost up
to 25% weight due to the parasite; it has to be noted that
depleted mice lost 5% less weight compared to isotype
treated mice. After 15 days the latter started to gain weight
(Figures 4(a) and 4(b)), but did not reach their initial
weight.4 Journal of Biomedicine and Biotechnology
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Figure 3: Depletion with PC61 mAb partially eliminates Foxp3+ cells. BALB/c mice were injected with 200μgo fi s o t y p e( a )o rP C 6 1( b )
mAbip.Twodayslater,beforeinfection,animalswerebledandimmunoﬂuorescencefordetectionofFoxp3wascarriedout.Thelymphocyte
region was ﬁrst identiﬁed and gated by FSC and SSC characteristics, the CD4+ region was subgated, and 10,000 CD4+ events were captured.
Numbers indicate % of Foxp3+ cells within the CD4+ population. A representative analysis from one mouse per group is shown.
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Figure 4: Depletion of CD25+ cells induces mortality in BALB/c mice infected with T. gondii. Animals (n = 6) were injected ip with 200μg
of either isotype mAb (a) (◦ in (c)) or PC61 mAb (b) (• in (c)) and 2 days later they were infected perorally with 20 cysts of the ME49
strain of T. gondii. Weight ((a),(b)) and cumulative mortality (c) were recorded daily for 25 days. In (a) and (b), each line corresponds to
one mouse.
When mortality was analyzed, isotype-treated mice sur-
vived during the 25 day experiment, but 50% of PC61-
treated mice died <13 days post infection (dpi) (Figure 4(c)),
although this result was not statistically signiﬁcant (P =
.0549). A similar result was observed when mice were
infected with 50 cysts, although we observed a higher
mortality rate (data not shown).
Analysis of blood samples of the same animals from
this experiment showed that although CD25+ cells were
eliminated, including Foxp3+ and Foxp3− cells, at later time
points, a marked increase in CD25+Foxp3− cells (Tact) was
observedindepletedanimals,whilethepercentageofFoxp3+
cells (Tregs) was still decreased (data not shown). Therefore,
we carried out an experiment to conﬁrm these observations.
We depleted and infected mice as described above, they
were killed 10 days pi, when animals showed symptoms of
toxoplasmosis (2–4 days before death) and an exhaustive
analysis of spleen cells was performed.
Analysis of Tregs and Tact cells from infected animals
at this time point (Figure 5) showed that infection induced
an expansion of Tact cells (3.76 versus 24.79). Depleted
infected animals, however, showed a dramatic expansion
of Tact when compared to depleted/noninfected animals
(0.94 versus 25.79), but no diﬀerence was detected between
Tact from infected nondepleted or depleted mice (24.79
versus 25.79), demonstrating that depletion did not prevent
activation of T cells. On the other hand, a nearly 50%
reduction in percentage of Tregs was observed in infected-
nondepleted animals, when compared to control mice (8.32
versus 16.35); depleted noninfected animals still showed a
50% decrease in Tregs at this time point (8.34 versus 16.35),
while depleted infected animals had 4.85% of Tregs, whichJournal of Biomedicine and Biotechnology 5
100 101 102 103
CD25-PE
(a)
100
101
102
103
2.16 14.19
3.76
F
o
x
p
3
-
A
l
e
x
a
F
l
u
o
r
4
8
8
Detection with PC61 mAb
Isotype
Isotype
100 101 102 103
CD25-PE
(c)
100
101
102
103
0.36 7.96
24.79
F
o
x
p
3
-
A
l
e
x
a
F
l
u
o
r
4
8
8
100 101 102 103
CD25-PE
(b)
100
101
102
103
4.14 4.2
0.94
PC61
PC61
100 101 102 103
CD25-PE
(d)
100
101
102
103
1.37 3.48
25.79
(a)
100 101 102 103
CD25-PE
(e)
100
101
102
103
2.79 12.94
3.06
Detection with 7D4 mAb
Isotype
100 101 102 103
CD25-PE
(g)
100
101
102
103
1.02 7.3
20.69
100 101 102 103
CD25-PE
(f)
100
101
102
103
3.93 3.52
0.99
PC61
100 101 102 103
CD25-PE
(h)
100
101
102
103
1.95 3.92
20.96
U
n
i
n
f
e
c
t
e
d
I
n
f
e
c
t
e
d
Isotype PC61
(b)
Figure 5: Analysis of Tregs and Tact cells after PC61 injection and infection with T. gondii. Animals were depleted and infected as described
in Figure 4. At 10dpi spleens were obtained and immunoﬂuorescence was carried out using anti-CD4-PerCP, anti-Foxp3-Alexa Fluor 488
and anti-CD25-PE mAb, either PC61 (a)–(d) or 7D4 clone (e)–(h). The lymphocyte region was ﬁrst identiﬁed and gated by FSC and SSC
characteristics, the CD4+ region was subgated, and 10,000 CD4+ events were captured. Numbers indicate % of cells from the CD4+ gating.
A representative analysis from one mouse per group is shown.
represents a 50% reduction when compared to noninfected-
depletedmice(4.85versus8.34).Alltheseresultsweresimilar
when mAb 7D4 was used to detect CD25 cells (Figure 5),
demonstrating no interference in the detection of CD25 with
PC61 mAb.
A summary of the results obtained from all mice studied
is depicted in Figure 6. Analysis shows that at 10dpi (12 days
post depletion) 50% of Tregs are still lacking in depleted
noninfected animals. Interestingly, infection induces a 50%
reduction of Tregs, but depleted infected animals have 50%
less Tregs than nondepleted infected mice, and only 25% of
Tregs when compared to control noninfected mice. Analysis
of Tact cells conﬁrmed that infection leads to a dramatic
expansion of this subset, which is not altered by depletion,
since mean percentage of Tact cells was unaﬀected, although
a high dispersion in data was observed (Figure 6).
When the ratio of Tact/Tregs cells was calculated
(Figure 7), we found that in noninfected animals, whether
depleted or nondepleted, ratios remained nearly unchanged
(≤ 0.28). In infected mice, a higher ratio was observed (1.2–
4.0), indicating a expansion of Tact cells due to the parasite.
In depleted/infected mice, however, the ratio was 0.5–12.7
(Figure 7(a)): a group of 4 mice showed a very high ratio
(>5.0), while another group presented a low ratio (0.5–1.15).
The day we carried out this experiment, one animal was
moribund,anditsspleencellsshowedthehighestproportion
of Tact/Tregs (ratio = 12.7, Figure 7(a)) .I th a st ob en o t e d
that in this experiment, an additional group of mice was
used to evaluate mortality (Figure 7(b)), and we found that
60% of animals died 15 days pi, which correlates to the
percentage of mice with the higher proportion of Tact/Tregs
(Figure 7(a)). All these experiments show that although the
generation of Tact cells due to infection is not altered by
depletion,thepercentageofTregsremainedverylow,turning
susceptible a resistant strain of mice.
In the present work we analyzed the role of Tregs during
infection with T. gondii in the resistant BALB/c strain of
mice. We observed that infected animals showed a decreased
number of Treg cells, a result which agrees with that reported
by Ge et al. [43], who showed that in pregnant and nonpreg-
nant mice, infection with T. gondii induced a reduction in
Foxp3 mRNA expression levels in spleen and a reduction in
both percentage and absolute number of Tregs. Thus, this
parasite induces a decline in Tregs percentage [43]. These6 Journal of Biomedicine and Biotechnology
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Figure 6: Summary of the Treg and Tact cell detection in mice after PC61 injection and infection with T. gondii.P e r c e n t a g eo fT r e g s( C D 4 +
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Figure 7: Infection with T. gondii induces an imbalance in Tact: Tregs cell ratio and is exacerbated by depletion. (a) Ratio of Tact: Tregs
(CD4+CD25+Foxp3− cells : CD4+Foxp3+ cells) was calculated from data obtained from Figure 6. (b) An additional group of mice (n = 5)
treated with isotype ( )o rP C 6 1( ) was used to evaluate cumulative mortality for 30 days.
results diﬀer from those observed during the acute phase
of other infections (P. berghei, S. mansoni, Heligmosomoides
polygyrus, Mycobacterium tuberculosis, Plasmodium yoelii,
Brugia malayi, and L. sigmodontis), in which an increase in
Foxp3+ cell number is observed [32, 39, 44–48]. In T. gondii
infection, it is possible that Tregs die or migrate to other
sites in order to control the immune response locally, as it
has been shown during P. berghei infection [39]. It has to be
noted that T. gondii can infect all cell types and disseminates
to most organs [49, 50]. The fate of Tregs during T. gondii
infection, however, remains currently unknown.
Injection of PC61 to deplete CD25+ cells has been widely
used to study the role of Tregs in diﬀerent models [32, 36, 37,
39, 42, 51, 52]. In our depletion experiments, we observed
that 50–60% of BALB/c mice died during the acute phase
of infection, an observation that suggests that Tregs play anJournal of Biomedicine and Biotechnology 7
importantroleintoxoplasmosis.However,sinceCD25isalso
expressed by other cell types, injection of the mAb leads also
to the depletion of Tact cells and interpretation of results
should be taken carefully.
We used a low single dose (200μg) of PC61 mAb, which
was enough to eliminate 50% of Tregs. These observations
agree with those reported previously [37], in which a partial
depletion of Tregs cells is observed after injection of PC61
mAb.
Injection of PC61 mAb initially eliminates 50% of Tregs,
but in infected mice this reduction is exacerbated due to
the infection, reaching 75% Tregs reduction in these animals
at 10 days pi, when compared to nondepleted-noninfected
mice. However, depletion did not hinder the activation of
T cells after T. gondii infection. In fact, levels of CD69
expression and percentage of CD69+ cells were similar
in Foxp3− cells from nondepleted infected and depleted
infected mice (data not shown), demonstrating that both
groups generate the same proportion of Tact cells.
While this work was carried out, Couper et al. [41]
reported that depletion using 1mg of the PC61 mAb leads
to an increased susceptibility of male C57BL/6J mice to the
ME49 strain of T. gondii. Although the results in mortality
obtained in our work are similar, we used the highly resistant
BALB/c strain of mice, in contrast to the highly susceptible
C57BL/6Jstrain.Moreover,wedepletedanimalswithalower
concentration of PC61 mAb to lessen undesirable eﬀects in
other cell populations; a single dose of mAb (200μg), 2 days
before infection was enough to achieve a 50% elimination
of Tregs. We avoided the use of higher concentrations of
PC61 mAb because we think that this would induce a
broad and long lasting depletion of CD25+ cells (both
Tact and Tregs) making more diﬃcult the interpretation of
the results.
The use of a suitable concentration of the PC61 mAb
a l l o w e du st od e t e c tad i ﬀerence in the proportions of Tact
andTregcells10dayspi.Thus,theamountofPC61antibody
did not prevent the generation of Tact cells due to the
infection. The levels of Treg, however, remained low during
infection, leading to the loss of resistance of the BALB/c
strain. These results show that the absence of Tregs alters the
protective immune response against T. gondii and thus mice
become susceptible.
T. gondii inducestheactivationofCD4+ andCD8+ Tcells
that are crucial to control infection [53]. These cells could in
turn be controlled by Tregs, as it has been demonstrated in
the T. congolense infection [31]. Our results show that Tregs
play an important role in the modulation of the protective
immune response against T. gondii. Since infection with this
parasite drives a powerful TH1 immune response [53], it
is tempting to speculate that the absence of Tregs induces
an uncontrolled inﬂammatory response by Tact cells. The
speciﬁc molecules and cells directly responsible for the death
of animals, however, remain to be established.
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